Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 360

1.

bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.

Xiong N, Yang H, Liu L, Xiong J, Zhang Z, Zhang X, Jia M, Huang J, Zhang Z, Mohamed AA, Lin Z, Wang T.

Environ Toxicol Pharmacol. 2013 Sep;36(2):411-22. doi: 10.1016/j.etap.2013.05.005. Epub 2013 May 22.

PMID:
23770451
2.

Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.

Zhang N, Zhou H, Wang H, Yu L, Li Z, Xu H, Wang M.

Transplant Proc. 2013 Mar;45(2):719-25. doi: 10.1016/j.transproceed.2012.09.120.

PMID:
23498812
3.
4.

Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.

Xiong N, Cao X, Zhang Z, Huang J, Chen C, Zhang Z, Jia M, Xiong J, Liang Z, Sun S, Lin Z, Wang T.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1519-29. doi: 10.1016/j.bbmt.2010.06.004. Epub 2010 Jun 10.

5.

Intrastriatal transplantation of mouse bone marrow-derived stem cells improves motor behavior in a mouse model of Parkinson's disease.

Offen D, Barhum Y, Levy YS, Burshtein A, Panet H, Cherlow T, Melamed E.

J Neural Transm Suppl. 2007;(72):133-43.

PMID:
17982886
6.

Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.

Fu W, Zheng Z, Zhuang W, Chen D, Wang X, Sun X, Wang X.

Int J Neurosci. 2013 Dec;123(12):883-91. doi: 10.3109/00207454.2013.814132. Epub 2013 Aug 1.

PMID:
23768098
7.

Basic fibroblast growth factor increases the transplantation‑mediated therapeutic effect of bone mesenchymal stem cells following traumatic brain injury.

Liu Y, Yi XC, Guo G, Long QF, Wang XA, Zhong J, Liu WP, Fei Z, Wang DM, Liu J.

Mol Med Rep. 2014 Jan;9(1):333-9. doi: 10.3892/mmr.2013.1803. Epub 2013 Nov 15.

PMID:
24248266
8.

Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.

Ye M, Wang XJ, Zhang YH, Lu GQ, Liang L, Xu JY, Chen SD.

Brain Res. 2007 Apr 20;1142:206-16. Epub 2006 Dec 24.

PMID:
17336273
9.

LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.

Yang XY, Zhao EY, Zhuang WX, Sun FX, Han HL, Han HR, Lin ZJ, Pan ZF, Qu MH, Zeng XW, Ding Y.

Neurol Sci. 2015 Nov;36(11):2027-33. doi: 10.1007/s10072-015-2295-x. Epub 2015 Jul 14.

PMID:
26169757
10.

Bone marrow-derived mesenchymal stem cells expressing the Shh transgene promotes functional recovery after spinal cord injury in rats.

Jia Y, Wu D, Zhang R, Shuang W, Sun J, Hao H, An Q, Liu Q.

Neurosci Lett. 2014 Jun 24;573:46-51. doi: 10.1016/j.neulet.2014.05.010. Epub 2014 May 15.

PMID:
24837681
11.

Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.

Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC.

Cell Transplant. 2009;18(7):801-14. doi: 10.3727/096368909X470801. Epub 2009 Sep 28.

PMID:
19796495
12.

VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease.

Xiong N, Zhang Z, Huang J, Chen C, Zhang Z, Jia M, Xiong J, Liu X, Wang F, Cao X, Liang Z, Sun S, Lin Z, Wang T.

Gene Ther. 2011 Apr;18(4):394-402. doi: 10.1038/gt.2010.152. Epub 2010 Nov 25.

PMID:
21107440
14.

Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.

Park S, Kim E, Koh SE, Maeng S, Lee WD, Lim J, Shim I, Lee YJ.

Brain Res. 2012 Jul 23;1466:158-66. doi: 10.1016/j.brainres.2012.05.032. Epub 2012 May 24.

PMID:
22634376
15.

Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.

Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC.

J Neurosci Res. 2010 Sep;88(12):2669-81. doi: 10.1002/jnr.22435.

PMID:
20544825
16.

Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.

Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.

Brain. 2010 Jan;133(Pt 1):189-204. doi: 10.1093/brain/awp290. Epub 2009 Dec 7.

PMID:
19995872
17.

Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.

Cova L, Armentero MT, Zennaro E, Calzarossa C, Bossolasco P, Busca G, Lambertenghi Deliliers G, Polli E, Nappi G, Silani V, Blandini F.

Brain Res. 2010 Jan 22;1311:12-27. doi: 10.1016/j.brainres.2009.11.041. Epub 2009 Nov 26.

PMID:
19945443
18.

Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopamine neurons mediated by the Lmx1a and neurturin in vitro: potential therapeutic application for Parkinson's disease in a rhesus monkey model.

Yan M, Sun M, Zhou Y, Wang W, He Z, Tang D, Lu S, Wang X, Li S, Wang W, Li H.

PLoS One. 2013 May 28;8(5):e64000. doi: 10.1371/journal.pone.0064000. Print 2013.

19.

Stem cells with FGF4-bFGF fused gene enhances the expression of bFGF and improves myocardial repair in rats.

Chen XQ, Chen LL, Fan L, Fang J, Chen ZY, Li WW.

Biochem Biophys Res Commun. 2014 Apr 25;447(1):145-51. doi: 10.1016/j.bbrc.2014.03.131. Epub 2014 Apr 6.

PMID:
24717649
20.

Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.

Mine Y, Hayashi T, Yamada M, Okano H, Kawase T.

Neurosurgery. 2009 Oct;65(4):741-53; discussion 753. doi: 10.1227/01.NEU.0000351281.45986.76. Erratum in: Neurosurgery. 2009 Dec;65(6):1062.

PMID:
19834380

Supplemental Content

Support Center